MXPA03011715A - Moleculas de agrecanasa. - Google Patents

Moleculas de agrecanasa.

Info

Publication number
MXPA03011715A
MXPA03011715A MXPA03011715A MXPA03011715A MXPA03011715A MX PA03011715 A MXPA03011715 A MX PA03011715A MX PA03011715 A MXPA03011715 A MX PA03011715A MX PA03011715 A MXPA03011715 A MX PA03011715A MX PA03011715 A MXPA03011715 A MX PA03011715A
Authority
MX
Mexico
Prior art keywords
aggrecanase
disclosed
enzymes
aggrecanase molecules
molecules
Prior art date
Application number
MXPA03011715A
Other languages
English (en)
Spanish (es)
Inventor
R Lavallie Edward
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MXPA03011715A publication Critical patent/MXPA03011715A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
MXPA03011715A 2001-07-05 2002-07-05 Moleculas de agrecanasa. MXPA03011715A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30305101P 2001-07-05 2001-07-05
US34913302P 2002-01-16 2002-01-16
PCT/US2002/021056 WO2003004607A2 (en) 2001-07-05 2002-07-05 Aggrecanase molecules

Publications (1)

Publication Number Publication Date
MXPA03011715A true MXPA03011715A (es) 2004-03-19

Family

ID=26973233

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03011715A MXPA03011715A (es) 2001-07-05 2002-07-05 Moleculas de agrecanasa.

Country Status (9)

Country Link
US (1) US20030148306A1 (https=)
EP (1) EP1409658A4 (https=)
JP (1) JP2004533841A (https=)
BR (1) BR0210835A (https=)
CA (1) CA2451374A1 (https=)
MX (1) MXPA03011715A (https=)
NZ (1) NZ530949A (https=)
PL (1) PL367675A1 (https=)
WO (1) WO2003004607A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2475329A1 (en) * 2002-02-05 2003-08-14 Katy E. Georgiadis Truncated aggrecanase molecules
AU2003261269A1 (en) * 2002-07-29 2004-02-16 Wyeth Modified adamts4 molecules and method of use thereof
BRPI0414423A (pt) * 2003-09-16 2006-11-14 Pharmacia Corp inibidores de pace4, suas composições farmacêuticas e respectivos usos
EP1737973A1 (en) * 2004-04-16 2007-01-03 Wyeth Truncated adamts molecules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419446A (en) * 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
CA2383592A1 (en) * 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx
JP2001008687A (ja) * 1999-06-25 2001-01-16 Yamanouchi Pharmaceut Co Ltd 新規金属プロテアーゼ及び該金属プロテアーゼ遺伝子
EP1234042A1 (en) * 1999-10-25 2002-08-28 Millennium Pharmaceuticals, Inc. Protein 27875, a human adam-ts homolog
EP1134286A3 (en) * 2000-03-14 2003-05-02 Pfizer Products Inc. Adamts polypeptides, nucleic acids encoding them, and uses thereof

Also Published As

Publication number Publication date
PL367675A1 (en) 2005-03-07
WO2003004607A3 (en) 2003-07-31
US20030148306A1 (en) 2003-08-07
JP2004533841A (ja) 2004-11-11
CA2451374A1 (en) 2003-01-16
EP1409658A4 (en) 2006-08-23
WO2003004607A2 (en) 2003-01-16
EP1409658A2 (en) 2004-04-21
NZ530949A (en) 2005-09-30
BR0210835A (pt) 2004-07-13

Similar Documents

Publication Publication Date Title
SG166001A1 (en) Methods of generating and screening for proteases with altered specificity
SG158739A1 (en) Aggrecanase molecules
ATE530643T1 (de) Säureaktive fungale protease
HUP0300369A2 (hu) Többértékű antitestek és alkalmazásuk
ATE346938T1 (de) Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
DK1337629T3 (da) Dipeptidylpeptidaser
MXPA02002901A (es) Enzimas de ruta de enfocado lisosomal.
DE10345772A1 (de) Verfahren zur Herstellung von 3-Methylamino-1-(thien-2-yl)-propan-1-ol
DE69939901D1 (de) Verfahren und materialien zur herstellung von glucosamin
PL1668001T3 (pl) Podstawione heteroarylobenzofuranowe kwasy
DE60023860D1 (de) Verfahren zur herstellung von rekombinanten peptiden
DE602004024686D1 (de) Cephalosporin-c-acylase-mutante und verfahren zur herstellung von 7-aca damit
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
EP1483384A4 (en) PROCESS FOR OVEREXPRESSING ZWITTERIONIC POLYSACCHARIDES
ATE324386T1 (de) Verfahren zum quellen
MXPA03011715A (es) Moleculas de agrecanasa.
IL149416A0 (en) Human enzymes of the metalloprotease family
WO2002033093A3 (en) Aggrecanase molecules
WO2003064597A3 (en) Aggrecanase molecules
DK1458869T3 (da) Alleler af glucokinasegenet af coryneforme bakterier
MXPA03003425A (es) Moleculas de agrecanasa novedosas.
WO2002042439A3 (en) Aggrecanase adamts9
SG160194A1 (en) Truncated aggrecanase molecules
WO2003012038A3 (en) Aggrecanase molecules
WO2003057842A3 (en) Aggrecanase molecules